The hidden switches underlying RORα-mediated circuits that critically regulate uncontrolled cell proliferation.

Prostaglandin E2 (PGE2) is known to have a key role in the development of colorectal cancer, but previous experiments showed its contrasting (i.e. tumor-promoting or tumor-suppressive) roles depending on experimental conditions. To elucidate the mechanisms underlying such contrasting roles of PGE2 in tumorigenesis, we investigated all the previous experiments and found a new signal transduction pathway mediated by retinoic acid receptor-related orphan receptor (ROR)α, in which PGE2/PKCα-dependent phosphorylation of RORα attenuates Wnt target gene expression in colon cancer cells. From mathematical simulations combined with biochemical experimentation, we revealed that RORα induces a biphasic response of Wnt target genes to PGE2 stimulation through a regulatory switch formed by an incoherent feedforward loop, which provides a mechanistic explanation on the contrasting roles of PGE2 observed in previous experiments. More interestingly, we found that RORα constitutes another regulatory switch formed by coupled positive and negative feedback loops, which regulates the hysteretic response of Wnt signaling and eventually converts a proliferative cellular state into an anti-proliferative state in a very delicate way. Our results indicate that RORα is the key regulator at the center of these hidden switches that critically regulate cancer cell proliferation and thereby being a promising anti-cancer therapeutic target.

[1]  M. Weller,et al.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor , 2011, Nature.

[2]  L. Gudas,et al.  Retinoids, retinoic acid receptors, and cancer. , 2011, Annual review of pathology.

[3]  K. Druey,et al.  Prostaglandin E2 Promotes Colon Cancer Cell Growth Through a Gs-Axin-ß-Catenin Signaling Axis , 2005, Science.

[4]  S. Narumiya,et al.  Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. , 1999, Cancer research.

[5]  Hans Clevers,et al.  Negative Feedback Loop of Wnt Signaling through Upregulation of Conductin/Axin2 in Colorectal and Liver Tumors , 2002, Molecular and Cellular Biology.

[6]  S. Dey,et al.  Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. , 2005, Cancer research.

[7]  A. Moschetta,et al.  Nuclear receptors, intestinal architecture and colon cancer: an intriguing link , 2008, Cellular and Molecular Life Sciences.

[8]  Y. Sugimoto,et al.  Molecular mechanisms of diverse actions of prostanoid receptors. , 1995, Biochimica et biophysica acta.

[9]  John D. Minna,et al.  Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer , 2010, PLoS medicine.

[10]  C. Albanese,et al.  The cyclin D 1 gene is a target of the b-catenin y LEF-1 pathway , 1999 .

[11]  C. Potten,et al.  The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice. , 2000, Cancer research.

[12]  M. Hull,et al.  Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? , 2004, Molecular cancer therapeutics.

[13]  Hemant K Roy,et al.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. , 2002, Carcinogenesis.

[14]  Hans Clevers,et al.  Caught up in a Wnt storm: Wnt signaling in cancer. , 2003, Biochimica et biophysica acta.

[15]  Choun-Ki Joo,et al.  Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.

[16]  W. de Souza,et al.  Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells , 2008, BMC Cell Biology.

[17]  Rami N. Hannoush,et al.  Kinetics of Wnt-Driven β-Catenin Stabilization Revealed by Quantitative and Temporal Imaging , 2008, PloS one.

[18]  Hee June Choi,et al.  Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes , 2005, Nature.

[19]  S. Dey,et al.  Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ , 2004 .

[20]  T. Hla,et al.  Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Kwang-Hyun Cho,et al.  The biphasic behavior of incoherent feed-forward loops in biomolecular regulatory networks. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  S. Narumiya,et al.  Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. , 2002, Cancer research.

[24]  Onn Brandman,et al.  Feedback Loops Shape Cellular Signals in Space and Time , 2008, Science.

[25]  M. Rosenfeld,et al.  RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. , 2010, Molecular cell.

[26]  M. Wiesmann,et al.  Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/β-catenin signaling is activated in human colon tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Heather R. Roberts,et al.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. , 2009, Carcinogenesis.

[28]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[29]  R. DuBois,et al.  COX-2: a molecular target for colorectal cancer prevention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Rodriguez,et al.  Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. , 2009, Molecular biology of the cell.

[31]  M. Kay Washington,et al.  Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells* , 2001, The Journal of Biological Chemistry.

[32]  C. Harris,et al.  Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. , 2003, Cancer research.

[33]  G. Xiong,et al.  RORα suppresses breast tumor invasion by inducing SEMA3F expression. , 2012, Cancer research.

[34]  Yukihiko Sugimoto,et al.  Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003, The Journal of experimental medicine.

[35]  Jack Xin,et al.  A Critical Quantity for Noise Attenuation in Feedback Systems , 2010, PLoS Comput. Biol..

[36]  A. C. Williams,et al.  Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer. , 2006, Biochimica et biophysica acta.

[37]  D. Kojetin,et al.  Regulation of p53 Stability and Apoptosis by a ROR Agonist , 2012, PloS one.

[38]  Christopher K. Glass,et al.  Exchange of N-CoR Corepressor and Tip60 Coactivator Complexes Links Gene Expression by NF-κB and β-Amyloid Precursor Protein , 2002, Cell.

[39]  J. Faivre,et al.  Chemoprevention of colorectal cancer. , 1999, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[40]  Kwang-Hyun Cho,et al.  The regulatory circuits for hysteretic switching in cellular signal transduction pathways , 2012, The FEBS journal.

[41]  Kwang-Hyun Cho,et al.  A hidden incoherent switch regulates RCAN1 in the calcineurin–NFAT signaling network , 2011, Journal of Cell Science.

[42]  B. Rigas,et al.  Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. , 1995, Biochimica et biophysica acta.

[43]  Jens Timmer,et al.  Systems-level interactions between insulin–EGF networks amplify mitogenic signaling , 2009, Molecular systems biology.

[44]  Kwang-Hyun Cho,et al.  The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor. , 2012, Journal of molecular cell biology.

[45]  S. Ramaswamy,et al.  Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.

[46]  Kevin Struhl,et al.  An HNF4α-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis , 2011, Cell.

[47]  Ignacio Rubio,et al.  Role of cAMP in the promotion of colorectal cancer cell growth by Prostaglandin E2 , 2008, BMC Cancer.

[48]  G. Krishnaswamy,et al.  Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. , 1997, Experimental cell research.

[49]  T. Sugimura,et al.  Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. , 2001, Anticancer research.

[50]  T. Sugimura,et al.  Enhancement of colon carcinogenesis by prostaglandin E2 administration. , 2003, Carcinogenesis.

[51]  E. Gelmann,et al.  Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[53]  A. C. Williams,et al.  Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. , 2006, Cancer research.

[54]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[55]  Wendy S. Wright,et al.  Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors* , 2002, The Journal of Biological Chemistry.

[56]  Kwang-Hyun Cho,et al.  Attractor Landscape Analysis Reveals Feedback Loops in the p53 Network That Control the Cellular Response to DNA Damage , 2012, Science Signaling.

[57]  A. Tarnawski,et al.  Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy , 2002, Nature Medicine.

[58]  Yukihiko Sugimoto,et al.  Host Prostaglandin E 2-EP 3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth , 2003 .

[59]  Kwang-Hyun Cho,et al.  Dynamics of biological systems: role of systems biology in medical research , 2006, Expert review of molecular diagnostics.

[60]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.